IDOV-Immune for Advanced Solid Tumors

Clinical trial NCT06910657 · RECRUITING

Trial details

NCT number: NCT06910657
Sponsor: ViroMissile, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Colorectal Cancer Pancreatic Cancer Melanoma Ovarian Cancer Gastric Cancer Esophageal Cancer Hepatocellular Carcinoma Renal Cell Carcinoma Breast Cancer Sarcoma Bladder Cancer Lung Cancer

Start date: 2025-08-25
Primary completion: 2027-01-31
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.